Evidence map›Paper›PMID 24756516›Full record

ArticleJAMA

Outcome after conservative management or intervention for unruptured brain arteriovenous malformations.

Rustam Al-Shahi Salman, Philip M White, Carl E Counsell, Johann du Plessis, Janneke van Beijnum, Colin B Josephson, Tim Wilkinson, Catherine J Wedderburn, Zoe Chandy, E Jerome St George and 3 more

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in JAMA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 223 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Interventions for treating brain arteriovenous malformations in adults.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Epilepsy Secondary to a Giant AVM: A Case Report.Case reports in vascular medicine · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 5 countries.

Rustam Al-Shahi SalmanDivision of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland.
Philip M WhiteInstitute for Ageing and Health, Newcastle University, Newcastle-upon-Tyne, England.
Carl E CounsellDivision of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland.
Johann du PlessisInstitute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland.
Janneke van BeijnumDepartment of Neurosurgery, Leiden University Medical Center, Leiden, the Netherlands.
Colin B JosephsonDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Tim WilkinsonDivision of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland.
Catherine J WedderburnUniversity College London Institute for Global Health, London, England.
Zoe ChandyDivision of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland.
E Jerome St GeorgeInstitute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland.
Robin J SellarDivision of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland.
Charles P WarlowDivision of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland.
Scottish Audit of Intracranial Vascular Malformations Collaborators
University of Edinburgh · GBInstitute of Neurological Sciences · ITLeiden University Medical Center · NLNewcastle Hospitals - Campus for Ageing and Vitality · GBSouthern General Hospital · GBUniversity College London · GBUniversity of Aberdeen · GBUniversity of Calgary · CA

Funding

Chief Scientist Office CZB/4/35Chief Scientist Office K/MRS/50/C2704Medical Research Council G0902303Medical Research Council G1002605Medical Research Council G108/613Medical Research Council G84/5176
6 · The paper itself

Abstract

importanceWhether conservative management is superior to interventional treatment for unruptured brain arteriovenous malformations (bAVMs) is uncertain because of the shortage of long-term comparative data.

objectiveTo compare the long-term outcomes of conservative management vs intervention for unruptured bAVM. DESIGN, SETTING, AND POPULATION: Population-based inception cohort study of 204 residents of Scotland aged 16 years or older who were first diagnosed as having an unruptured bAVM during 1999-2003 or 2006-2010 and followed up prospectively for 12 years. EXPOSURES: Conservative management (no intervention) vs intervention (any endovascular embolization, neurosurgical excision, or stereotactic radiosurgery alone or in combination). MAIN OUTCOMES AND MEASURES: Cox regression analyses, with multivariable adjustment for prognostic factors and baseline imbalances if hazards were proportional, to compare rates of the primary outcome (death or sustained morbidity of any cause by Oxford Handicap Scale [OHS] score ≥2 for ≥2 successive years [0 = no symptoms and 6 = death]) and the secondary outcome (nonfatal symptomatic stroke or death due to bAVM, associated arterial aneurysm, or intervention).

resultsOf 204 patients, 103 underwent intervention. Those who underwent intervention were younger, more likely to have presented with seizure, and less likely to have large bAVMs than patients managed conservatively. During a median follow-up of 6.9 years (94% completeness), the rate of progression to the primary outcome was lower with conservative management during the first 4 years of follow-up (36 vs 39 events; 9.5 vs 9.8 per 100 person-years; adjusted hazard ratio, 0.59; 95% CI, 0.35-0.99), but rates were similar thereafter. The rate of the secondary outcome was lower with conservative management during 12 years of follow-up (14 vs 38 events; 1.6 vs 3.3 per 100 person-years; adjusted hazard ratio, 0.37; 95% CI, 0.19-0.72). CONCLUSIONS AND RELEVANCE: Among patients aged 16 years or older diagnosed as having unruptured bAVM, use of conservative management compared with intervention was associated with better clinical outcomes for up to 12 years. Longer follow-up is required to understand whether this association persists.

Indexed as

Embolization, TherapeuticRadiosurgeryWatchful WaitingAdultAgedCohort StudiesFemaleHumansIntracranial Arteriovenous MalformationsMaleMiddle AgedNeurosurgical ProceduresScotlandSurvival AnalysisTreatment Outcome

Identifiers

PMID24756516
OpenAlexW2080492343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.